Investor insights
Sectors invested in
Biotechnology5
Health Care3
Alzheimer's Disease2
Medical Device2
Phenotyping2
Retinal Imaging2
Diagnostic Imaging2
Medical Devices2
Dementia2
Artificial Intelligence2
non-invasive cancer diagnostics1
Genetics1
Medical1
Health Diagnostics1
Diagnostics1
Chronic Kidney Disease1
Kidney Injury1
Kidney Health1
Kidney Transplantation1
Funding rounds participated in
$9.8M sweet spot round size
Most of their 5 investments are in rounds between $3.1M and $16M
Investor type
Private Equity Firm
Venture Capital
Basic info
Industry
venture capital and private equity principals
Sectors
Date founded
2019
Investments made
G
GLX Analytix raised undisclosed on June 14, 2022
Investors: CBC Investment Group AB and DigitalDx Ventures
O
Optina Diagnostics raised $20M on October 28, 2021
Investors: MEDTEQ, Hike Ventures, Desjardins Entreprises - Capital régional et coopératif and DigitalDx Ventures
N
Nephrosant, Inc. raised $16M on March 16, 2021
Investors: DaVita Venture Group and DigitalDx Ventures
P
Prime Genomics raised $3.5M on November 1, 2018
Investors: DigitalDx Ventures
O
Optina Diagnostics raised $3.1M on October 10, 2018
Investors: Zoic Capital, Desjardins Entreprises - Capital régional et coopératif, -, Hike Ventures and DigitalDx Ventures